Scarica l'app Stockscreener
4.91
3.59%
0.17
Dopo l'orario di chiusura:
4.91
Precedente Chiudi:
$4.74
Aprire:
$4.66
Volume 24 ore:
9,842
Relative Volume:
0.39
Capitalizzazione di mercato:
$9.43M
Reddito:
$7.70M
Utile/perdita netta:
$-33.38M
Rapporto P/E:
-0.3988
EPS:
-12.3134
Flusso di cassa netto:
$-39.92M
1 W Prestazione:
+6.74%
1M Prestazione:
+25.58%
6M Prestazione:
-18.23%
1 anno Prestazione:
-28.84%
Intervallo 1D:
$4.66
$5.015
Intervallo di 1 settimana:
$4.50
$5.1311
Portata 52W:
$3.91
$9.248
Bolt Biotherapeutics Inc Stock (BOLT) Company Profile
Nome
Bolt Biotherapeutics Inc
Settore
Industria
Telefono
650-665-9295
Indirizzo
900 CHESAPEAKE DRIVE, REDWOOD CITY
Compare BOLT vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BOLT
Bolt Biotherapeutics Inc
|
4.91 | 9.11M | 7.70M | -33.38M | -39.92M | -12.31 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-20 | Ripresa | H.C. Wainwright | Buy |
| 2022-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-03-02 | Iniziato | Guggenheim | Buy |
| 2021-03-02 | Iniziato | Morgan Stanley | Overweight |
| 2021-03-02 | Iniziato | SVB Leerink | Outperform |
| 2021-03-02 | Iniziato | Stifel | Buy |
Mostra tutto
Bolt Biotherapeutics Inc Borsa (BOLT) Ultime notizie
Aug Movers: Is Bolt Biotherapeutics Inc still a buy after recent gainsMarket Activity Summary & Verified Momentum Stock Ideas - baoquankhu1.vn
Treasury Yields: Will Bolt Biotherapeutics Inc announce a stock splitWeekly Loss Report & Daily Volume Surge Trade Alerts - baoquankhu1.vn
BOLT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Performance Recap: Is Bolt Biotherapeutics Inc still a buy after recent gains2026 Buyback Activity & Stepwise Swing Trade Plans - baoquankhu1.vn
Technical Analysis: Will Bolt Biotherapeutics Inc announce a stock splitTrade Exit Report & Community Consensus Stock Picks - baoquankhu1.vn
Sentiment Watch: Is Bolt Biotherapeutics Inc on track to beat earnings2026 Outlook & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Income Plays: Is Bolt Biotherapeutics Inc impacted by rising ratesEarnings Summary Report & Weekly Setup with High ROI Potential - baoquankhu1.vn
Entry Recap: Is Bolt Biotherapeutics Inc undervalued by DCF analysisInsider Selling & High Conviction Investment Ideas - baoquankhu1.vn
Institution Moves: What is the long term forecast for Bolt Biotherapeutics Inc stock2026 Price Action Summary & Growth Focused Entry Reports - baoquankhu1.vn
Fund Flows: Is Bolt Biotherapeutics Inc still a buy after recent gains2026 Breakouts & Weekly Return Optimization Alerts - baoquankhu1.vn
Aug Sectors: What are Bolt Biotherapeutics Incs earnings expectationsTrade Entry Report & AI Powered Market Entry Ideas - baoquankhu1.vn
Momentum Shift: Is Bolt Biotherapeutics Inc still a buy after recent gains2026 Institutional & Stepwise Trade Signal Guides - baoquankhu1.vn
Trend Recap: Will Bolt Biotherapeutics Inc outperform its industry peersWeekly Trade Analysis & Long Hold Capital Preservation Tips - baoquankhu1.vn
Bolt Biotherapeutics discloses new STING agonist immunoconjugates - BioWorld News
Bronstein, Gewirtz and Grossman, LLC sends a Class Action Lawsuit reminder to shareholder investors for Bolt Biotherapeutics, Inc. to Lead the Class Action Lawsuit! - ACCESS Newswire
CEO Change: Is Bolt Biotherapeutics Inc on track to beat earnings2026 Chart Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
Bolt Biotherapeutics (BOLT) to Release Quarterly Earnings on Wednesday - Defense World
If You Invested $1,000 in Bolt Biotherapeutics, Inc. (BOLT) - Stock Titan
Buyout Rumor: Is Bolt Biotherapeutics Inc undervalued by DCF analysisInsider Buying & Technical Pattern Based Signals - baoquankhu1.vn
Market Outlook: Is Bolt Biotherapeutics Inc likely to announce a buybackEarnings Miss & Short-Term Swing Trade Alerts - baoquankhu1.vn
Market Leaders: Is Bolt Biotherapeutics Inc likely to announce a buyback2026 Action & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Sell Signal: Will Bolt Biotherapeutics Inc outperform its industry peersPortfolio Gains Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
What is the long term forecast for Bolt Biotherapeutics Inc stock2026 News Drivers & Fast Gain Stock Tips - baoquankhu1.vn
Weekly Earnings: Is Bolt Biotherapeutics Inc stock a smart retirement pick2026 Bull vs Bear & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Fundamentals Check: Does Bolt Biotherapeutics Inc have strong EBITDA margins2026 Bull vs Bear & Community Consensus Trade Signals - baoquankhu1.vn
Whats the outlook for Bolt Biotherapeutics Incs sector2026 Analyst Calls & Long Hold Capital Preservation Plans - baoquankhu1.vn
Market Outlook: Is Bolt Biotherapeutics Inc stock a smart retirement pick2026 Weekly Recap & High Conviction Trade Alerts - baoquankhu1.vn
HC Wainwright Reiterates Buy Rating for Bolt Biotherapeutics (BO - GuruFocus
Bolt Biotherapeutics Inc.: Q4 Earnings Snapshot - theheraldreview.com
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update - Bitget
Bolt Biotherapeutics 2025 Financials: Loss Narrows to $33.4MNews and Statistics - IndexBox
Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Bolt Biotherapeutics Inc.: Fourth Quarter Financial Results Overview - Bitget
BOLT Reports Q4 Revenue Surpassing Expectations - GuruFocus
Bolt Biotherapeutics 10-K: $7.7M Revenue, $(17.85) EPS - TradingView
Bolt Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Cost cuts help Bolt Biotherapeutics (NASDAQ: BOLT) halve 2025 loss - Stock Titan
Bolt tests new gastric cancer drug, $31.8M cash into 2027 - Stock Titan
Take Profit: Is Bolt Biotherapeutics Inc a speculative investmentMarket Volume Report & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Sees Large Growth in Short Interest - Defense World
Bolt Biotherapeutics, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Can Bolt Biotherapeutics Inc. stock maintain growth trajectoryEarnings Recap Report & Real-Time Market Trend Scan - Naître et grandir
Is Bolt Biotherapeutics Inc. (6LP0) stock overpriced at current multiplesDividend Hike & Step-by-Step Swing Trade Plans - Naître et grandir
BOLTBolt Biotherapeutics, Inc. Latest Stock News & Market Updates - Stock Titan
Is Bolt Biotherapeutics Inc likely to announce a buybackJuly 2025 Technicals & Reliable Trade Execution Plans - baoquankhu1.vn
BOLT SEC FilingsBolt Biotherapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Portfolio Update: Will Bolt Biotherapeutics Inc announce a stock splitJuly 2025 Selloffs & Reliable Intraday Trade Alerts - baoquankhu1.vn
Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy? - MSN
Bolt Biotherapeutics to Participate in Upcoming March Conferences - Bitget
Ideas Watch: Is Bolt Biotherapeutics Inc a speculative investmentProduct Launch & Technical Pattern Alert System - baoquankhu1.vn
BOLT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Bolt Biotherapeutics Inc Azioni (BOLT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):